Wells Fargo’s Redhill Biopharma RDHL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-1
| Closed | -$9 | – | 7042 |
|
|
2024
Q2 | $9 | Hold |
1
| – | – | ﹤0.01% | 6645 |
|
|
2024
Q1 | $12 | Hold |
1
| – | – | ﹤0.01% | 7253 |
|
|
2023
Q4 | $34 | Hold |
1
| – | – | ﹤0.01% | 7039 |
|
|
2023
Q3 | $12 | Hold |
1
| – | – | ﹤0.01% | 7352 |
|
|
2023
Q2 | $28 | Sell |
1
-1
| -50% | -$58 | ﹤0.01% | 7214 |
|
|
2023
Q1 | $196 | Hold |
2
| – | – | ﹤0.01% | 6776 |
|
|
2022
Q4 | $272 | Hold |
2
| – | – | ﹤0.01% | 6538 |
|
|
2022
Q3 | $1K | Hold |
2
| – | – | ﹤0.01% | 6439 |
|
|
2022
Q2 | $2K | Buy |
2
+1
| +100% | +$1.37K | ﹤0.01% | 6361 |
|
|
2022
Q1 | $2K | Sell |
1
-2
| -67% | -$4.74K | ﹤0.01% | 6692 |
|
|
2021
Q4 | $7K | Sell |
3
-281
| -99% | -$1.12M | ﹤0.01% | 6642 |
|
|
2021
Q3 | $1.3M | Buy |
284
+26
| +10% | +$176K | ﹤0.01% | 4027 |
|
|
2021
Q2 | $1.78M | Buy |
258
+58
| +29% | +$400K | ﹤0.01% | 3785 |
|
|
2021
Q1 | $1.47M | Buy |
200
+65
| +48% | +$545K | ﹤0.01% | 3973 |
|
|
2020
Q4 | $1.09M | Sell |
135
-2
| -1% | -$18K | ﹤0.01% | 3967 |
|
|
2020
Q3 | $1.4M | Buy |
137
+136
| +13,600% | +$1.12M | ﹤0.01% | 3605 |
|
|
2020
Q2 | $9K | Hold |
1
| – | – | ﹤0.01% | 5869 |
|
|
2020
Q1 | $4K | Hold |
1
| – | – | ﹤0.01% | 5903 |
|
|
2019
Q4 | $5K | Sell |
1
-1
| -50% | -$6.39K | ﹤0.01% | 6043 |
|
|
2019
Q3 | $17K | Buy |
2
+1
| +100% | +$7.28K | ﹤0.01% | 5843 |
|
|
2019
Q2 | $6K | Hold |
1
| – | – | ﹤0.01% | 6010 |
|
|
2019
Q1 | $7K | Hold |
1
| – | – | ﹤0.01% | 5688 |
|
|
2018
Q4 | $5K | Hold |
1
| – | – | ﹤0.01% | 6077 |
|
|
2018
Q3 | $8K | Hold |
1
| – | – | ﹤0.01% | 6042 |
|
|
2018
Q2 | $8K | Hold |
1
| – | – | ﹤0.01% | 6007 |
|
|
2018
Q1 | $3K | Hold |
1
| – | – | ﹤0.01% | 6149 |
|
|
2017
Q4 | $3K | Sell |
1
-2
| -67% | -$13.5K | ﹤0.01% | 6146 |
|
|
2017
Q3 | $35K | Hold |
3
| – | – | ﹤0.01% | 5571 |
|
|
2017
Q2 | $24K | Hold |
3
| – | – | ﹤0.01% | 5593 |
|
|
2017
Q1 | $27K | Buy |
3
+1
| +50% | +$9.99K | ﹤0.01% | 5640 |
|
|
2016
Q4 | $21K | Hold |
2
| – | – | ﹤0.01% | 5614 |
|
|
2016
Q3 | $27K | Sell |
2
-1
| -33% | -$14K | ﹤0.01% | 5514 |
|
|
2016
Q2 | $33K | Sell |
3
-1
| -25% | -$11.6K | ﹤0.01% | 5339 |
|
|
2016
Q1 | $49K | Hold |
4
| – | – | ﹤0.01% | 5227 |
|
|
2015
Q4 | $52K | Hold |
4
| – | – | ﹤0.01% | 5262 |
|
|
2015
Q3 | $52K | Buy |
4
+1
| +33% | +$14.8K | ﹤0.01% | 5251 |
|
|
2015
Q2 | $53K | Hold |
3
| – | – | ﹤0.01% | 5308 |
|
|
2015
Q1 | $44K | Hold |
3
| – | – | ﹤0.01% | 5069 |
|
|
2014
Q4 | $40K | Hold |
3
| – | – | ﹤0.01% | 5099 |
|
|
2014
Q3 | $40K | Hold |
3
| – | – | ﹤0.01% | 5018 |
|
|
2014
Q2 | $52K | Hold |
3
| – | – | ﹤0.01% | 4962 |
|
|
2014
Q1 | $42K | Buy |
+3
| New | +$40.2K | ﹤0.01% | 4980 |
|
Other funds holding RDHL
FDCDDQ
CPA
DB
IA
Wells Fargo's RDHL Position: Q3 2024 in Review
Wells Fargo sold out of Redhill Biopharma (RDHL) in Q3 2024, closing a stake of 1 share — an estimated $9 sold.
Wells Fargo first reported a position in RDHL in Q1 2014 and held it in 42 quarters. The position peaked at $1.78M in Q2 2021. 11 funds tracked by Wall St. Rank hold RDHL as of Q3 2024.
- Wells Fargo reported no remaining Redhill Biopharma position as of Q3 2024 after selling out during the quarter.
- Wells Fargo sold 1 Redhill Biopharma share in Q3 2024, an estimated $9.
- Wells Fargo first reported a position in Redhill Biopharma in Q1 2014 and held it in 42 quarters.
- Wells Fargo's Redhill Biopharma position peaked at $1.78M in Q2 2021.
- 11 funds tracked by Wall St. Rank held Redhill Biopharma as of Q3 2024.
Based on Wells Fargo's 13F filing for Q3 2024, filed 13 Nov 2024.